Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 319.5 TWD 1.75%
Market Cap: 85.3B TWD

Intrinsic Value

The intrinsic value of one Lotus Pharmaceutical Co Ltd stock under the Base Case scenario is 559.66 TWD. Compared to the current market price of 319.5 TWD, Lotus Pharmaceutical Co Ltd is Undervalued by 43%.

Intrinsic Value
559.66 TWD
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Lotus Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Lotus Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Lotus Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Lotus Pharmaceutical Co Ltd.

Explain Valuation
Compare Lotus Pharmaceutical Co Ltd to
Custom
Choose any stock to compare

Fundamental Analysis

Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Lotus Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Lotus Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

Price Targets Summary
Lotus Pharmaceutical Co Ltd

Wall Street analysts forecast Lotus Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Lotus Pharmaceutical Co Ltd is 473.28 TWD with a low forecast of 395.92 TWD and a high forecast of 630 TWD.

Lowest
Price Target
395.92 TWD
24% Upside
Average
Price Target
473.28 TWD
48% Upside
Highest
Price Target
630 TWD
97% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Lotus Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Lotus Pharmaceutical Co Ltd stock?

The intrinsic value of one Lotus Pharmaceutical Co Ltd stock under the Base Case scenario is 559.66 TWD.

Is Lotus Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 319.5 TWD, Lotus Pharmaceutical Co Ltd is Undervalued by 43%.

Back to Top